Conferences

News & Press

Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a distribution agreement with XIFIN, a …

Read More

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing as a first-line diagnostic test …

Read More

Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround times. This new software solution, called Fabric Hereditary Panels with ACE (AI Classification Engine), will debut at the ACMG annual meeting in Seattle, Washington. The solution incorporates an extensively validated, automated ACMG classification …

Read More

Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and their patients to complement Diagnomics’ portfolio of Personalized Genomics. Diagnomics has partnered with Fabric Genomics to use Fabric Enterprise, its clinical decision-support platform, to generate clinical insights for the report.

Read More

Fabric Genomics and Genomenon announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant classification. Fabric Genomics speeds and scales genomic interpretation by combining the most advanced AI algorithms with automated workflows, while Genomenon’s literature search engine facilitates comprehensive literature review, which is advantageous for …

Read More

CHICAGO (GenomeWeb) – From the beginning, Fabric Genomics (formerly Omicia) has developed a unique solution for phenotype-driven genome interpretation from whole genome and exome data. The company is expanding into more hospital systems and clinical lab worldwide. “Our goal is to bring this now to every single hospital and every single testing lab around the …

Read More

Fabric Genomics was recently highlighted in the San Francisco Business Times. Martin Reese, CEO, discussed how Fabric is transforming health care with clinical insights through AI interpretations of genomes, exomes, and panels for hereditary diseases and cancer. “We provide the software; the labs provide the genomics data,” said Reese. “We then do machine learning with …

Read More

Fabric Genomics announced that its proprietary clinical genomics platform has been selected by 10 new commercial partners across four continents, including Africa, Asia, Europe and North America. The company’s software is allowing these organizations to provide genomics leadership and state-of-the art clinical genomics testing in their respective countries. The new customers consist of hospitals, clinical …

Read More
play_circle_outline

Fabric Genomics is a software genomics company that provides end-to-end genomic data analysis, annotation, curation, classification, and reporting solutions to clinical labs, hospital labs, life science companies, country sequencing programs, and research institutions. The organization’s machine-learning technologies and advanced proprietary algorithms VAAST and Phevor enable scientists to quickly and accurately process and analyze whole genomes, …

Read More

This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomics will announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to clinical labs. The offering enables therapy matching for cancer patients, giving clinicians targeted treatment choices for cancer patients. Now clinical labs have one integrated platform for the interpretation …

Read More

Fabric Genomics has partnered with Genomics England’s 100,000 Genomes Project, Rady Children’s Institute for Genomic Medicine (RCIGM), and The Utah Genome Project (UGP), to provide fast and accurate identification of pediatric disease-causing variants to improve the clinical care of children. Fabric Genomics’ Opal™ Clinical is the only genomic interpretation and reporting platform to include the algorithms VAAST and Phevor, two pioneering …

Read More

Today at the American Society for Human Genetics (ASHG) Annual Meeting, Edico Genome and Fabric Genomics announced their collaboration to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data. Through this partnership, users can seamlessly utilize Edico Genome’s DRAGENTM Bio-IT platform with Fabric Genomics’ Opal™ Clinical variant interpretation platform to accurately gain biological insights into …

Read More

Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing examination of its patients’ genomic data to augment data analysis and annotation in collaboration …

Read More

Fabric Genomics, a global computational genomics company offering data analysis and clinical reporting tools, announced today that it has partnered with data management company ITTM S.A. (Information Technology for Translational Medicine) to provide secure genomic data hosting capabilities for EU customers. By combining Fabric Genomics’ leading analysis tools with ITTM’s proven secure hosting and infrastructure …

Read More

Fabric Genomics, a global computational genomics company, and TOMA Biosciences, a genomic cancer diagnostics company, announced today a partnership that will bring together premier chemistry and informatics platforms for deepened genomic analysis of cancer and delivery of clinically meaningful information for tumor profiling. The companies will co-develop an end-to-end oncology genomic testing and clinical interpretation …

Read More

Fabric Genomics, a global computational genomics company, and Veritas Genetics, the global leader in genetic sequencing and interpretation, announced today at the ACMG Annual Clinical Genetics Meeting that they have entered into a technology partnership. The goal of the collaboration is to accelerate Veritas’ myGenome product for personal whole genome sequencing using Fabric Genomics’ new …

Read More